Aurora Cannabis Inc.(ACB)Earnings, Financials & Key Ratios
ACB•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryCannabis and cannabinoid product companies
AboutAurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.Show more
- Revenue$321M-6.4%
- EBITDA-$149M-641.9%
- Net Income-$122M-7772.8%
- EPS (Diluted)-2.15-7643.9%
- Gross Margin5.21%-90.5%
- EBITDA Margin-46.35%-678.7%
- Operating Margin-50.78%-3623.1%
- Net Margin-37.98%-8294.1%
- ROE-21.83%-8389.0%
ACB Key Insights
Aurora Cannabis Inc. (ACB) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y profit CAGR of 29.4%
- ✓Trading at only 0.5x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 16 (bottom 16%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ACB posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ACB Price & Volume
Aurora Cannabis Inc. (ACB) stock price & volume — 10-year historical chart
Loading chart...
ACB Growth Metrics
Aurora Cannabis Inc. (ACB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years71.75%
5 Years5.56%
3 Years12.82%
TTM-9.45%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-4815.84%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-4556.4%
Return on Capital
10 Years-12.37%
5 Years-15.14%
3 Years-10.53%
Last Year-25.64%
ACB Recent Earnings
Aurora Cannabis Inc. (ACB) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 5/12 qtrs (42%)
Q3 2026Latest
Jun 11, 2026Metric
Actual
Est
EPS
$0.07+200.0%
$0.07
Rev
$61M+12.0%
$54M
Q1 2026
Feb 4, 2026Metric
Actual
Est
EPS
$0.09-7.4%
$0.10
Rev
$69M+2.0%
$67M
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$0.09+200.0%
$0.03
Rev
$63M-28.4%
$88M
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$0.19-205.6%
$0.18
Rev
$65M-30.9%
$94M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q3 2026Latest | Jun 11, 2026 | $0.07vs $0.07+200.0% | $61Mvs $54M+12.0% |
| Q1 2026 | Feb 4, 2026 | $0.09vs $0.10-7.4% | $69Mvs $67M+2.0% |
| Q4 2025 | Nov 5, 2025 | $0.09vs $0.03+200.0% | $63Mvs $88M-28.4% |
| Q3 2025 | Aug 6, 2025 | $0.19vs $0.18-205.6% | $65Mvs $94M-30.9% |
Based on last 12 quarters of dataView full earnings history →
ACB Peer Comparison
Aurora Cannabis Inc. (ACB) competitors in Cannabis and cannabinoid product companies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CGC | 372.36M | 0.97 | -1.55 | 79.81% | -117.39% | -49.5% | 0.33 | |
 TLRY | 551.15M | 4.73 | -0.14 | 4.84% | -252.55% | -136.55% | 0.22 | |
 CRON | 1.01B | 2.71 | -110.61 | 64.4% | -0.98% | -0.18% | 0.00 | |
 OGI | 135.81M | 0.96 | -9.72 | 16.42% | -9.7% | -6.76% | 0.03 | |
 SMG | 3.75B | 64.69 | 26.19 | -3.93% | 2.68% | |||
 IIPR | 1.7B | 59.60 | 15.17 | -13.8% | 45.58% | 6.41% | 0.21 | |
 HYFM | 4.35M | 0.91 | -0.01 | -29.45% | -237.25% | -5% | ||
 LWAY | 388.62M | 25.43 | 28.57 | 13.74% | 6.54% | 17.76% | 0.01 |
Compare ACB vs Peers
Aurora Cannabis Inc. (ACB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ACB Income Statement
Aurora Cannabis Inc. (ACB) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 55.2M | 245.54M | 268.7M | 245.25M | 221.34M | 223.8M | 270.28M | 343.29M | 321.42M |
Revenue Growth % | 205.51% | 344.84% | 9.44% | -8.73% | -9.75% | 1.11% | 20.77% | 27.01% | -6.37% |
Cost of Goods Sold | 11.68M | 103.1M | 288.64M | 266.81M | 200.11M | 209.02M | 138.82M | 155.69M | 304.67M |
COGS % of Revenue | 21.16% | 41.99% | 107.42% | 108.79% | 90.41% | 93.39% | 51.36% | 45.35% | 94.79% |
Gross Profit | 43.52M▲ 0% | 142.44M▲ 227.3% | -19.93M▼ 114.0% | -21.56M▼ 8.1% | 21.23M▲ 198.5% | 14.78M▼ 30.3% | 131.46M▲ 789.2% | 187.61M▲ 42.7% | 16.75M▼ 91.1% |
Gross Margin % | 78.84% | 58.01% | -7.42% | -8.79% | 9.59% | 6.61% | 48.64% | 54.65% | 5.21% |
Gross Profit Growth % | 171.05% | 227.31% | -114% | -8.14% | 198.46% | -30.35% | 789.2% | 42.71% | -91.07% |
Operating Expenses | 139.29M | 460.72M | 445.85M | 261.26M | 252.67M | 221.98M | 177.91M | 182.66M | 179.96M |
OpEx % of Revenue | 252.36% | 187.64% | 165.93% | 106.53% | 114.16% | 99.18% | 65.83% | 53.21% | 55.99% |
Selling, General & Admin | 109.86M | 365.38M | 345.75M | 194.88M | 188.99M | 170.47M | 156.88M | 166.47M | 173.95M |
SG&A % of Revenue | 199.04% | 148.81% | 128.67% | 79.46% | 85.39% | 76.17% | 58.04% | 48.49% | 54.12% |
Research & Development | 1.68M | 14.78M | 26.03M | 11.45M | 10.39M | 5.77M | 3.57M | 3.68M | 6.01M |
R&D % of Revenue | 3.04% | 6.02% | 9.69% | 4.67% | 4.69% | 2.58% | 1.32% | 1.07% | 1.87% |
Other Operating Expenses | 27.75M | 80.56M | 74.07M | 54.94M | 53.29M | 45.73M | 17.46M | 12.52M | 5.79M |
Operating Income | -95.77M▲ 0% | -318.28M▼ 232.3% | -465.78M▼ 46.3% | -282.82M▲ 39.3% | -231.45M▲ 18.2% | -207.19M▲ 10.5% | -46.45M▲ 77.6% | 4.95M▲ 110.7% | -163.21M▼ 3398.6% |
Operating Margin % | -173.51% | -129.63% | -173.34% | -115.32% | -104.57% | -92.58% | -17.19% | 1.44% | -50.78% |
Operating Income Growth % | -755.72% | -232.33% | -46.34% | 39.28% | 18.16% | 10.48% | 77.58% | 110.65% | -3398.58% |
EBITDA | -83.51M | -230.02M | -351.06M | -184.74M | -137.79M | -154.6M | -13.38M | 27.5M | -148.99M |
EBITDA Margin % | -151.3% | -93.68% | -130.65% | -75.33% | -62.25% | -69.08% | -4.95% | 8.01% | -46.35% |
EBITDA Growth % | -726.44% | -175.44% | -52.62% | 47.38% | 25.42% | -12.2% | 91.34% | 305.46% | -641.86% |
D&A (Non-Cash Add-back) | 12.26M | 88.25M | 114.72M | 98.08M | 93.66M | 52.59M | 33.07M | 22.55M | 14.23M |
EBIT | 89.09M | -291.24M | -3.26B | -633.36M | -1.65B | -187.59M | -45.41M | 28.8M | -163.21M |
Net Interest Income | -9.25M | -35.73M | -70.2M | -60.69M | -67.31M | -20.46M | -1.37M | 3.08M | 4.05M |
Interest Income | 2.52M | 3.68M | 5.91M | 5.75M | 4.51M | 19M | 12.81M | 11.51M | 5.86M |
Interest Expense | 11.76M | 39.41M | 76.11M | 66.44M | 71.81M | 39.46M | 14.19M | 8.42M | 1.81M |
Other Income/Expense | 173.1M | -12.37M | -2.87B | -416.98M | -1.49B | -576.51M | -13.15M | 15.43M | 106.54M |
Pretax Income | 77.33M▲ 0% | -330.65M▼ 527.6% | -3.34B▼ 910.1% | -699.8M▲ 79.0% | -1.72B▼ 145.8% | -783.7M▲ 54.4% | -59.6M▲ 92.4% | 20.38M▲ 134.2% | -56.67M▼ 378.0% |
Pretax Margin % | 140.1% | -134.66% | -1242.91% | -285.34% | -777.14% | -350.17% | -22.05% | 5.94% | -17.63% |
Income Tax | 8.1M | -29.91M | -82.23M | -6.32M | -2.14M | 16.55M | -554K | 4.62M | 2.1M |
Effective Tax Rate % | 10.47% | 9.05% | 2.46% | 0.9% | 0.12% | -2.11% | 0.93% | 22.66% | -3.71% |
Net Income | 71.94M▲ 0% | -293.51M▼ 508.0% | -3.28B▼ 1018.4% | -693.63M▲ 78.9% | -1.72B▼ 147.6% | -816.63M▲ 52.5% | -69.33M▲ 91.5% | 1.59M▲ 102.3% | -122.07M▼ 7772.8% |
Net Margin % | 130.33% | -119.54% | -1221.68% | -282.82% | -776.02% | -364.88% | -25.65% | 0.46% | -37.98% |
Net Income Growth % | 654.72% | -508.01% | -1018.43% | 78.87% | -147.63% | 52.46% | 91.51% | 102.3% | -7772.83% |
Net Income (Continuing) | 69.23M | -300.74M | -3.26B | -693.48M | -1.72B | -800.25M | -59.05M | 15.76M | -58.77M |
Discontinued Operations | 0 | 144K | -51.86M | -1.61M | -21.6M | -23.66M | -10.28M | -14.17M | -63.3M |
Minority Interest | 4.59M | 4.43M | -24.25M | 0 | 31.06M | 31.06M | 42.17M | 41.18M | 0 |
EPS (Diluted) | 18.00▲ 0% | -36.65▼ 303.6% | -333.92▼ 811.1% | -40.92▲ 87.7% | -79.92▼ 95.3% | -8.17▲ 89.8% | -1.28▲ 84.3% | 0.03▲ 102.2% | -2.15▼ 7643.9% |
EPS Growth % | 400% | -303.61% | -811.11% | 87.75% | -95.31% | 89.78% | 84.33% | 102.23% | -7643.86% |
EPS (Basic) | 18.77 | -36.65 | -333.92 | -40.92 | -79.92 | -8.17 | -1.28 | 0.03 | -2.15 |
Diluted Shares Outstanding | 3.93M | 8.01M | 9.68M | 16.91M | 21.49M | 32.27M | 51.26M | 55.75M | 56.71M |
Basic Shares Outstanding | 4M | 8.01M | 9.83M | 16.95M | 21.49M | 32.27M | 51.26M | 54.88M | 56.71M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
ACB Balance Sheet
Aurora Cannabis Inc. (ACB) balance sheet — assets, liabilities & shareholders' equity
| Metric | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 221.2M | 663.1M | 415.75M | 665.05M | 479.96M | 479.96M | 427.35M | 475.58M | 398.48M |
Cash & Short-Term Investments | 150.4M | 363.42M | 168.53M | 444.04M | 300.86M | 300.86M | 183.58M | 184.81M | 165.12M |
Cash Only | 90.8M | 219.63M | 161.49M | 440.3M | 300.86M | 300.86M | 179.53M | 184.26M | 112.77M |
Short-Term Investments | 59.59M | 143.8M | 7.04M | 3.75M | 0 | 0 | 4.04M | 550.82K | 52.35M |
Accounts Receivable | 15.2M | 112.76M | 53.88M | 56.19M | 41.35M | 41.35M | 45.49M | 42.23M | 44.69M |
Days Sales Outstanding | 100.51 | 167.62 | 73.19 | 83.63 | 68.18 | 67.43 | 61.43 | 44.9 | 50.75 |
Inventory | 43.51M | 162.51M | 153.39M | 137.55M | 128.83M | 128.83M | 186.7M | 237.72M | 175.53M |
Days Inventory Outstanding | 1.36K | 575.34 | 193.97 | 188.17 | 234.98 | 224.97 | 490.89 | 557.32 | 210.28 |
Other Current Assets | 12.1M | 24.42M | 39.95M | 27.27M | 8.92M | 8.92M | 11.58M | 10.82M | 13.14M |
Total Non-Current Assets | 1.68B | 4.97B | 2.5B | 2.06B | 446.42M | 446.42M | 412.79M | 372.19M | 204.16M |
Property, Plant & Equipment | 248.04M | 768.49M | 942.39M | 605.33M | 322.99M | 322.99M | 294.84M | 266.57M | 124.01M |
Fixed Asset Turnover | 0.22x | 0.32x | 0.29x | 0.41x | 0.69x | 0.69x | 0.92x | 1.29x | 2.59x |
Goodwill | 765.96M | 3.18B | 923.97M | 886.62M | 18.72M | 18.72M | 43.26M | 43.62M | 26.72M |
Intangible Assets | 201.71M | 691M | 410.53M | 366.99M | 59.68M | 59.68M | 40.92M | 44.9M | 31.52M |
Long-Term Investments | 462.53M | 206.04M | 63.28M | 73.93M | 13.75M | 13.75M | 6.35M | 5.23M | 15.82M |
Other Non-Current Assets | 0 | 6.95M | 12.28M | 3.53M | 15.79M | 15.79M | 12.05M | 7.68M | 3.63M |
Total Assets | 1.9B▲ 0% | 5.64B▲ 196.8% | 2.92B▼ 48.3% | 2.72B▼ 6.7% | 926.38M▼ 66.0% | 926.38M▲ 0.0% | 840.14M▼ 9.3% | 847.77M▲ 0.9% | 602.64M▼ 28.9% |
Asset Turnover | 0.03x | 0.04x | 0.09x | 0.09x | 0.24x | 0.24x | 0.32x | 0.40x | 0.53x |
Asset Growth % | 486.57% | 196.82% | -48.26% | -6.71% | -65.96% | 0% | -9.31% | 0.91% | -28.91% |
Total Current Liabilities | 75.68M | 438.03M | 271.11M | 116.23M | 237.75M | 237.75M | 124.84M | 110.23M | 67.1M |
Accounts Payable | 47.78M | 38.82M | 19.62M | 13.26M | 21.94M | 21.94M | 20.36M | 27.46M | 9.33M |
Days Payables Outstanding | 1.49K | 137.43 | 24.81 | 18.14 | 40.02 | 38.32 | 53.53 | 64.38 | 11.18 |
Short-Term Debt | 2.47M | 250.62M | 151.97M | 40.89M | 147.56M | 147.56M | 57.32M | 26.74M | 5.74M |
Deferred Revenue (Current) | 2.28M | 1.48M | 3.49M | 4.16M | 1.74M | 1.74M | 1.69M | 1.07M | 1.27M |
Other Current Liabilities | 21.48M | 129.32M | 72.37M | 48.68M | 53.73M | 53.73M | 28.4M | 27.87M | 30.12M |
Current Ratio | 2.92x | 1.51x | 1.53x | 5.72x | 2.02x | 2.02x | 3.42x | 4.31x | 5.94x |
Quick Ratio | 2.35x | 1.14x | 0.97x | 4.54x | 1.48x | 1.48x | 1.93x | 2.16x | 3.32x |
Cash Conversion Cycle | -32.96 | 605.52 | 242.34 | 253.65 | 263.14 | 254.08 | 498.79 | 537.84 | 249.85 |
Total Non-Current Liabilities | 260.19M | 795.74M | 531.45M | 569.74M | 166.89M | 166.89M | 112.38M | 132.45M | 22.38M |
Long-Term Debt | 202.14M | 396.67M | 293.68M | 292.81M | 36.17M | 36.17M | 4.91M | 39.96M | 0 |
Capital Lease Obligations | 0 | 0 | 83.35M | 65.35M | 42.68M | 42.68M | 37.56M | 37.28M | 18.18M |
Deferred Tax Liabilities | 55.78M | 208.97M | 152.56M | 119.65M | 16.75M | 16.75M | 16.22M | 1.89M | 0 |
Other Non-Current Liabilities | 0 | 190.1M | 1.86M | 91.93M | 71.3M | 71.3M | 53.69M | 53.32M | 4.21M |
Total Liabilities | 335.87M | 1.23B | 802.56M | 685.97M | 404.64M | 404.64M | 237.22M | 242.67M | 89.49M |
Total Debt | 204.6M | 647.29M | 529.01M | 399.05M | 226.41M | 226.41M | 99.78M | 103.98M | 23.92M |
Net Debt | 113.8M | 427.66M | 367.51M | -41.25M | -74.45M | -74.45M | -79.75M | -80.28M | -88.85M |
Debt / Equity | 0.13x | 0.15x | 0.25x | 0.20x | 0.43x | 0.43x | 0.17x | 0.17x | 0.05x |
Debt / EBITDA | - | - | - | - | - | - | - | 3.78x | - |
Net Debt / EBITDA | - | - | - | - | - | - | - | -2.92x | - |
Interest Coverage | 7.57x | -7.39x | -42.88x | -9.53x | -22.95x | -4.75x | -3.20x | 3.42x | -89.99x |
Total Equity | 1.56B▲ 0% | 4.4B▲ 181.7% | 2.11B▼ 52.0% | 2.04B▼ 3.7% | 521.74M▼ 74.4% | 521.74M▲ 0.0% | 602.92M▲ 15.6% | 605.09M▲ 0.4% | 513.15M▼ 15.2% |
Equity Growth % | 611.66% | 181.67% | -51.99% | -3.74% | -74.36% | 0% | 15.56% | 0.36% | -15.19% |
Book Value per Share | 398.08 | 549.67 | 218.52 | 120.34 | 24.28 | 16.17 | 11.76 | 10.85 | 9.05 |
Total Shareholders' Equity | 1.56B | 4.4B | 2.14B | 2.04B | 490.67M | 490.67M | 560.75M | 563.91M | 513.15M |
Common Stock | 1.48B | 4.69B | 5.76B | 6.42B | 6.84B | 6.84B | 6.98B | 6.95B | 7.03B |
Retained Earnings | 88.35M | -287.41M | -3.58B | -4.32B | -6.29B | -6.29B | -6.38B | -6.33B | -6.46B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -5.86M | -3.5M | -41.63M | -65.43M | -58.33M | -58.33M | -43.78M | -55.91M | -214.15M |
Minority Interest | 4.59M | 4.43M | -24.25M | 0 | 31.06M | 31.06M | 42.17M | 41.18M | 0 |
ACB Cash Flow Statement
Aurora Cannabis Inc. (ACB) cash flow — operating, investing & free cash flow history
| Metric | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -81.67M | -192.25M | -342.14M | -210.58M | -110.27M | -115.82M | -68.51M | 16M | -13.55M |
Operating CF Margin % | -147.96% | -78.3% | -127.33% | -85.86% | -49.82% | -51.75% | -25.35% | 4.66% | -4.21% |
Operating CF Growth % | -510.46% | -135.4% | -77.97% | 38.45% | 47.64% | -5.04% | 40.85% | 123.36% | -184.64% |
Net Income | 69.23M | -300.74M | -3.26B | -693.48M | -1.72B | -265.33M | -57.08M | 15.76M | -58.77M |
Depreciation & Amortization | 12.26M | 88.25M | 114.72M | 98.08M | 93.66M | 43.57M | 32.77M | 22.55M | 14.23M |
Stock-Based Compensation | 37.45M | 107.04M | 59.18M | 20.24M | 13.76M | 16.89M | 12.72M | 11.52M | 7.29M |
Deferred Taxes | 6.44M | -23.91M | -77.14M | -6.44M | -2.19M | -18.4M | -1.67M | -3.19M | 55.14K |
Other Non-Cash Items | -181.65M | -25.61M | 2.81B | 370.63M | 1.45B | 190.11M | -39.71M | -40.85M | 40.18M |
Working Capital Changes | -25.39M | -37.28M | 7.59M | 397K | 52.65M | -25.12M | -15.54M | 10.21M | -9.24M |
Change in Receivables | -12.36M | -68.52M | 55.16M | 7.37M | 18.34M | 5.53M | -4.5M | 5.24M | -8.17M |
Change in Inventory | -8.99M | -50.42M | -26.32M | 8.45M | 21.07M | 49.03M | 3.87M | -15.05M | 65.93M |
Change in Payables | 3.1M | 100.57M | -22.55M | -28.29M | 6.76M | -8.06M | -15.7M | 14.91M | -8.06M |
Cash from Investing | -536.85M | -312.3M | -245.43M | -26.91M | -36.17M | -27.29M | -3.36M | -14.33M | -73.62M |
Capital Expenditures | -136.94M | -414.19M | -348.81M | -53.08M | -32.21M | -12.13M | -16.83M | -18.86M | -22.6M |
CapEx % of Revenue | 248.11% | 168.69% | 129.81% | 21.64% | 14.55% | 5.42% | 6.23% | 5.49% | 7.03% |
Acquisitions | -335.57M | 114.35M | 27.88M | 0 | -23.42M | -18.54M | -5.54M | 0 | 1.1M |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | -895K | -8.85M | -13.34M | 14.78M | 19.46M | 16K | 14.02M | -956K | 235.61K |
Cash from Financing | 535.15M | 597.55M | 582.56M | 521.95M | 147.78M | -56.48M | -47.92M | -116K | 9.79M |
Debt Issued (Net) | 344.82M | 583.74M | -35.91M | -122.92M | -170.83M | - | -85.37M | -805K | -5.02M |
Equity Issued (Net) | 215.61M | 59.33M | 575.51M | 666.03M | 350.19M | - | 37.92M | 820K | 9.94M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -25.27M | -45.52M | 42.96M | -21.15M | -31.58M | -95.21M | -475K | -131K | -154.4K |
Net Change in Cash | -83.01M▲ 0% | 95.94M▲ 215.6% | -10.55M▼ 111.0% | 259.28M▲ 2558.1% | 16.35M▼ 93.7% | -140.01M▼ 956.3% | -119.5M▲ 14.7% | 1.83M▲ 101.5% | -66.81M▼ 3758.9% |
Free Cash Flow | -218.61M▲ 0% | -606.43M▼ 177.4% | -690.96M▼ 13.9% | -263.66M▲ 61.8% | -142.48M▲ 46.0% | -127.95M▲ 10.2% | -85.34M▲ 33.3% | -2.85M▲ 96.7% | -36.15M▼ 1166.6% |
FCF Margin % | -396.06% | -246.98% | -257.14% | -107.51% | -64.37% | -57.17% | -31.58% | -0.83% | -11.25% |
FCF Growth % | -459.17% | -177.4% | -13.94% | 61.84% | 45.96% | 10.2% | 33.3% | 96.66% | -1166.61% |
FCF per Share | -55.66 | -75.69 | -71.41 | -15.59 | -6.63 | -3.96 | -1.66 | -0.05 | -0.64 |
FCF Conversion (FCF/Net Income) | -1.14x | 0.65x | 0.10x | 0.30x | 0.06x | 0.14x | 0.99x | 10.06x | 0.11x |
Interest Paid | 7.07M | 18.05M | 47.9M | 34.16M | 27.73M | - | 14.87M | 6.84M | 2.35M |
Taxes Paid | - | - | - | - | - | - | - | 928K | 0 |
ACB Key Ratios
Aurora Cannabis Inc. (ACB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -11.5% | 8.07% | -9.84% | -100.72% | -33.43% | -134.35% | -156.52% | -12.33% | 0.26% | -21.83% |
Return on Invested Capital (ROIC) | -12.02% | -7.98% | -7.33% | -9.55% | -9.48% | -14.22% | -34.74% | -7.18% | 0.71% | -25.79% |
Gross Margin | 88.87% | 78.84% | 58.01% | -7.42% | -8.79% | 9.59% | 6.61% | 48.64% | 54.65% | 5.21% |
Net Margin | -71.78% | 130.33% | -119.54% | -1221.68% | -282.82% | -776.02% | -364.88% | -25.65% | 0.46% | -37.98% |
Debt / Equity | 0.29x | 0.13x | 0.15x | 0.25x | 0.20x | 0.43x | 0.43x | 0.17x | 0.17x | 0.05x |
Interest Coverage | -12.36x | 7.57x | -7.39x | -42.88x | -9.53x | -22.95x | -4.75x | -3.20x | 3.42x | -89.99x |
FCF Conversion | 1.03x | -1.14x | 0.65x | 0.10x | 0.30x | 0.06x | 0.14x | 0.99x | 10.06x | 0.11x |
Revenue Growth | 1155.52% | 205.51% | 344.84% | 9.44% | -8.73% | -9.75% | 1.11% | 20.77% | 27.01% | -6.37% |
Related:ACB Dividend History·ACB Revenue History·ACB Price History·ACB P/E History·ACB Financial Ratios·ACB Institutional Holders
ACB Frequently Asked Questions
Aurora Cannabis Inc. (ACB) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Aurora Cannabis Inc. (ACB) reported $310.9M in revenue for fiscal year 2026.
Aurora Cannabis Inc. (ACB) saw revenue decline by 6.4% over the past year.
Aurora Cannabis Inc. (ACB) reported a net loss of $75.0M for fiscal year 2026.
Dividend & Returns
Aurora Cannabis Inc. (ACB) has a return on equity (ROE) of -21.8%. Negative ROE indicates the company is unprofitable.
Aurora Cannabis Inc. (ACB) had negative free cash flow of $36.1M in fiscal year 2026, likely due to heavy capital investments.